Post #163 by DTB on the Non-US Stocks board

Investment Strategies / Non-US Stocks

Unthreaded | Threaded | Whole Thread (4)

Post New | Post Reply | Report Post | Recommend It!

No. of Recommendations: 2

any thoughts ? down by half since 2024. wegovy weight loss now approved for China Market.

My thoughts are here: https://www.shrewdm.com/MB?pid=107629517

The price is a lot better now, down from $85 to $65, but I would still stay away, for the same reasons, i.e. the weakness of the semaglutide franchise. If I had to choose, I would buy the much more expensive Lilly, with better drugs and less vulnerable to generic competition.

dtb

Post New | Post Reply | Report Post | Recommend It!

Print the post

Unthreaded | Threaded | Whole Thread (4)

Prev | Next

Announcements

Non-US Stocks FAQ

Contact Shrewd'm
Contact the developer of these message boards.

A community forum supporting civilized, and highly helpful, self-educating investors that come together for Shrewdness and merry spirits. These message boards closely follow the look and feel of the old message boards at boards.fool.com prior to the boards redirected to discussion.fool.com. Shrewd'm is not affiliated with the comprehensive and excellent investment website, The Motley Fool (TMF), in any way. The Shrewd commmunity here has owed, and continues to owe, gratitude to The Motley Fool for nurturing a culture of jovial irreverence towards Wall St, and that tradition will continue here.